4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001104659-24-132166
Chief Accounting Officer sold 2,273 shares at $7.43 ($16,888)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Liao Carrie Chief Accounting Officer | 2024-12-26 | Sale 10b5-1 | −2,273 | $7.43 | $16,888 | 97,270 | D |
| Open-market sales · 2,273 sh · avg $7.43 · $16,888 | |||||||
Loading xslF345X05/tm2432133-3_4seq1.xml…